Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient Care
This activity has been supported through an independent educational grant from Teva Pharmaceuticals.
Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist’s Role in Advancing Patient Care
Mitra Habibi, PharmD
Clinical Assistant Professor
University of Illinois at Chicago
Clinical Pharmacist, Neurology
University of Illinois Hospital &
Health Sciences System
After participating in this activity, participants should be able to:
- Recall the incidence, etiology, and pathophysiology of multiple sclerosis (MS) and strategies to help patients understand the importance of treating early to slow disease progression.
- Discuss the available disease-modifying therapies and explain strategies to improve patient adherence to these agents, including patient assistance programs.
- Provide patient counseling information regarding medications available to treat exacerbations and manage symptoms of MS.
- Evaluate emerging therapies for the treatment of MS.
Type of activity:
December 8, 2014
December 8, 2016
Estimated time to complete activity:
This lesson is offered free at www.pharmacytimes.org.
Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-14-110-H01-P. The activity is available for CE credit through December 8, 2016.